Inhaled Delivery Technologies and Product Development
Expert Guidance in Inhaled Delivery Technologies and Product Development
By Senior Adviser Gunilla Petersson, PhD
At Emmace, we pride ourselves on offering unparalleled expertise and guidance throughout the entire drug product development process. Here’s how we can elevate your project.
Drug Delivery Technologies – Development and Design
- Target Technology Profile: Defining the end goals for new particle, formulation or inhaler technologies
- Development: Data review, trouble shooting, quality control strategies
- Technology promotion: Support to development of capability presentations
- Drug Delivery Technologies: Support to selection of technologies and potential providers
- Integrated in Emmace lab flow: Conveniently and seamless involved in the generation of in vitro data
External Landscape – Technical Reviews
- Drugs and products: Pipeline drugs and marketed products
- Scientific marketing: Product profiling and promotion
- Due Diligences: Support to preparation, execution and summary of technology, product or company reviews
Product Development – From Early to Late Phase
- Development Process: Guiding teams through the process and facilitate planning and collaboration with non CMC teams
- Regulatory Documentation: Strategic input, review of file documents and answers to regulatory questions
- Technology Transfer : Guiding teams through the process
Scientific Development – Proposal and publications
- Expert review: critical evaluation to strengthen a draft proposal or publication
- Expert advice; scientific background in the field of inhalation
Gunilla Petersson, PhD
Senior Adviser – Inhaled Delivery Technologies and Product Development
Dr. Gunilla Petersson brings a multidisciplinary expertise in the field of inhalation pharmaceuticals covering development of analytical testing, formulations, devices, and registration of drug products. 30 years in big pharma involved in technology scouting, support to business development, commercial and marketing teams, with focus on competitor intelligence, scientific marketing, Due Diligences and external technology and company evaluations. Former member of EPAG and IPAC-RS Boards.
